These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12739705)

  • 1. Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn.
    Johnsson F; Hatlebakk JG; Klintenberg AC; Román J
    Scand J Gastroenterol; 2003 Apr; 38(4):347-53. PubMed ID: 12739705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.
    Johnsson F; Hatlebakk JG; Klintenberg AC; Román J; Toth E; Stubberöd A; Falk A; Edin R
    Scand J Gastroenterol; 2003 Apr; 38(4):354-9. PubMed ID: 12739706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of heartburn resolution and erosive esophagitis in patients with GERD.
    Orlando RC; Monyak JT; Silberg DG
    Curr Med Res Opin; 2009 Sep; 25(9):2091-102. PubMed ID: 19601705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment.
    Miner PB; Johnson DA; Katz PO; Li J; Gatoulis SC; Pollack C
    Adv Ther; 2018 Nov; 35(11):2024-2040. PubMed ID: 30255418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
    Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
    Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
    Johnson D; Crawley JA; Hwang C; Brown K
    Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo.
    Johnson DA; Le Moigne A; Li J; Pollack C; Nagy P
    Clin Drug Investig; 2016 Jul; 36(7):531-8. PubMed ID: 27074935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid resolution of sleep disturbances related to frequent reflux: effect of esomeprazole 20 mg in two randomized, double-blind, controlled trials.
    Johnson DA; Le Moigne A; Hugo V; Nagy P
    Curr Med Res Opin; 2015 Feb; 31(2):243-50. PubMed ID: 25478944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg.
    Eggleston A; Katelaris PH; Nandurkar S; Thorpe P; Holtmann G;
    Aliment Pharmacol Ther; 2009 May; 29(9):967-78. PubMed ID: 19210493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease.
    Dent J; Kahrilas PJ; Hatlebakk J; Vakil N; Denison H; Franzén S; Lundborg P
    Am J Gastroenterol; 2008 Jan; 103(1):20-6. PubMed ID: 18184117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.
    Richter JE; Peura D; Benjamin SB; Joelsson B; Whipple J
    Arch Intern Med; 2000 Jun; 160(12):1810-6. PubMed ID: 10871975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.
    Zeng J; Zuo XL; Li YQ; Wei W; Lv GP
    Eur J Clin Pharmacol; 2007 Jun; 63(6):529-36. PubMed ID: 17468863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis.
    Katz PO; Castell DO; Levine D
    Aliment Pharmacol Ther; 2003 Nov; 18(9):875-82. PubMed ID: 14616151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.
    Gillessen A; Beil W; Modlin IM; Gatz G; Hole U
    J Clin Gastroenterol; 2004 Apr; 38(4):332-40. PubMed ID: 15087692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 2-Week Data from Two Randomized, Controlled Trials Conducted in Subjects with Frequent Heartburn Treated with Esomeprazole 20 mg.
    Katz PO; Le Moigne A; Pollack C
    Clin Ther; 2017 May; 39(5):960-970. PubMed ID: 28431766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms.
    Scholten T; Gatz G; Hole U
    Aliment Pharmacol Ther; 2003 Sep; 18(6):587-94. PubMed ID: 12969085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole.
    Armstrong D; Talley NJ; Lauritsen K; Moum B; Lind T; Tunturi-Hihnala H; Venables T; Green J; Bigard MA; Mössner J; Junghard O
    Aliment Pharmacol Ther; 2004 Aug; 20(4):413-21. PubMed ID: 15298635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
    Moraes-Filho JP; Pedroso M; Quigley EM;
    Aliment Pharmacol Ther; 2014 Jan; 39(1):47-56. PubMed ID: 24299323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.